Transcatheter structural heart therapies stand to replace their open-heart counterparts thanks to technological innovations and expanded patient access.
Data show bioprosthetic surgical aortic valves featuring the RESILIA tissue platform continued to demonstrate favorable safety and hemodynamic performance.
Among other initiatives, Bay Labs will integrate its EchoMD measurement and interpretation software into Edwards’ CardioCare quality care navigation platform.